PCV79 - REAL-WORLD COST-EFFECTIVENESS OF RIVAROXABAN COMPARED WITH VITAMIN K ANTAGONISTS IN THE CONTEXT OF STROKE PREVENTION IN ATRIAL FIBRILLATION IN FRANCE
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.625
https://www.valueinhealthjournal.com/article/S1098-3015(18)33925-1/fulltext
Section Title :
Section Order :
37
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33925-1&doi=10.1016/j.jval.2018.09.625